StimAire
PrivateLast Round
Seed
Nov 18, 2019
Company Overview
StimAire operates in Healthcare & Life Sciences and is based in Tucson, Arizona. Its latest recorded funding round was a Seed round in November 2019.
StimAire is a medical device company that develops injectable neuromodulation technology for the treatment of obstructive sleep apnea and other conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StimAire Comparables
Compare StimAire with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avivomed | 91% | |
| Restera | 91% | |
| Vivamed, Inc. | 88% |
For institutional investors. Book with your work email.
StimAire Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
StimAire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Desert Angels | Seed |
StimAire Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StimAire's valuation, stock price, and market status.
Is StimAire a public or private company?
StimAire is a private company.
What is the current stock price of StimAire?
StimAire is a private company, so its shares have no public market price. Caplight tracks StimAire's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StimAire worth (valuation)?
Valuation information for StimAire is not publicly available.
Can I buy StimAire stock?
StimAire shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StimAire's last funding round?
StimAire's most recent funding round was Seed on November 18, 2019.
Who are the main investors in StimAire?
Key investors in StimAire include Desert Angels.
Will StimAire IPO soon?
No public IPO plans have been announced for StimAire.
How can I track StimAire secondary market activity?
Caplight tracks bids, offers, and trades in StimAire's shares on secondary markets.